BioGend Therapeutics Market Cap

BioGend Therapeutics has a market cap or net worth of 3.26 billion as of April 24, 2025. Its market cap has decreased by -29.42% in one year.

Market Cap

3.26B

Enterprise Value

2.68B

Revenue

167.65M

Ranking

n/a

PE Ratio

n/a

Stock Price

26.25

Market Cap Chart

Since June 18, 2019, BioGend Therapeutics's market cap has increased from 2.71B to 3.26B, an increase of 20.17%. That is a compound annual growth rate of 3.19%.

Market Cap History

Date	Market Cap	% Change
Apr 24, 2025	3.26B	-21.99%
Dec 31, 2024	4.18B	-11.18%
Dec 29, 2023	4.71B	109.50%
Dec 30, 2022	2.25B	-18.50%
Dec 30, 2021	2.76B	-22.86%
Dec 31, 2020	3.57B	46.27%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	160.86B
Caliway Biopharmaceuticals	93.07B
Bora Pharmaceuticals Co., LTD.	67.36B
Lotus Pharmaceutical	54.79B
Polaris Group	28.88B
Oneness Biotech	28.11B
Pegavision	25.35B
Lumosa Therapeutics	24.91B

Market Cap Rankings